NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+8.4%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.59B
AUM Growth
+$1.59B
(+11%)
Cap. Flow
+$35.6M
Cap. Flow
% of AUM
2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
234
New
31
Increased
64
Reduced
62
Closed
27
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$19.2M |
| 2 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$17.3M |
| 3 |
AMRS
Amyris Inc.
AMRS
|
$15.7M |
| 4 |
Establishment Labs
ESTA
|
$15.1M |
| 5 |
SQSP
Squarespace, Inc.
SQSP
|
$9.92M |
Top Sells
| 1 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$20M |
| 2 |
NovoCure
NVCR
|
$16.9M |
| 3 |
Seer Inc
SEER
|
$14.5M |
| 4 |
JetBlue
JBLU
|
$14.2M |
| 5 |
TFI International
TFII
|
$7.9M |
Sector Composition
| 1 | Healthcare | 44.51% |
| 2 | Technology | 13.21% |
| 3 | Financials | 6.93% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Industrials | 5.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $35.3M | 2.21% | 363,708 -11,946 | -3% | -$1.16M |
|
2
BridgeBio Pharma
BBIO
$9.89B
| $27.6M | 1.73% | 451,982 -37,641 | -8% | -$2.29M |
|
3
Repligen
RGEN
$6.88B
| $27.3M | 1.71% | 136,652 -5,451 | -4% | -$1.09M |
|
4
TG Therapeutics
TGTX
$4.65B
| $25.6M | 1.61% | 660,964 +35,177 | +6% | +$1.36M |
|
5
Kornit Digital
KRNT
$669M
| $25.6M | 1.6% | 205,667 -146 | -0.1% | -$18.2K |
|
6
Zai Lab
ZLAB
$3.68B
| $25.1M | 1.58% | 141,881 +3,659 | +3% | +$648K |
|
7
Avantor
AVTR
$9.18B
| $24.9M | 1.56% | 701,183 +20,283 | +3% | +$720K |
|
|
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $24.4M | 1.53% | 598,261 +43,716 | +8% | +$1.78M |
|
9
Twist Bioscience
TWST
$1.63B
| $24.4M | 1.53% | 182,967 +20,232 | +12% | +$2.7M |
|
10
argenx
ARGX
$43.6B
| $23.6M | 1.48% | 78,527 -7,601 | -9% | -$2.29M |
|
|
OSH
11
DELISTED
Oak Street Health, Inc.
OSH
| $22.5M | 1.41% | 383,390 +10,549 | +3% | +$618K |
|
12
Monolithic Power Systems
MPWR
$40B
| $22.3M | 1.4% | 59,819 +5,230 | +10% | +$1.95M |
|
13
Veeva Systems
VEEV
$44B
| $21.6M | 1.36% | 69,610 -854 | -1% | -$266K |
|
14
Exact Sciences
EXAS
$8.98B
| $21.5M | 1.35% | 173,168 +4,884 | +3% | +$607K |
|
15
NeoGenomics
NEO
$1.13B
| $21.4M | 1.34% | 473,264 +2,812 | +0.6% | +$127K |
|
|
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $21.3M | 1.34% | 227,839 -42,792 | -16% | -$4.01M |
|
17
Krystal Biotech
KRYS
$4.27B
| $21.3M | 1.34% | 313,454 +8,765 | +3% | +$596K |
|
18
Inspire Medical Systems
INSP
$2.77B
| $21.2M | 1.33% | 109,746 +8,700 | +9% | +$1.68M |
|
19
10x Genomics
TXG
$1.74B
| $21.1M | 1.32% | 107,801 +21,406 | +25% | +$4.19M |
|
|
CELL
20
DELISTED
PhenomeX Inc. Common Stock
CELL
| $20.5M | 1.29% | 458,376 +125,042 | +38% | +$5.6M |
|
|
21
Establishment Labs
ESTA
$1.2B
| $20.5M | 1.29% | 234,570 +172,330 | +277% | +$15.1M |
|
|
AMRS
22
DELISTED
Amyris Inc.
AMRS
| $20.4M | 1.28% | 1,248,778 +959,915 | +332% | +$15.7M |
|
23
Schrodinger
SDGR
$1.44B
| $20.4M | 1.28% | 269,194 +7,532 | +3% | +$570K |
|
|
ARNA
24
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $20.3M | 1.28% | 298,247 -29,695 | -9% | -$2.03M |
|
25
Goldman Sachs
GS
$226B
| $20.1M | 1.26% | 52,961 -5,000 | -9% | -$1.9M |
|